Jupiter Neurosciences, Inc. (JUNS)
0.4151
+0.04
(+10.05%)
USD |
NASDAQ |
Mar 20, 16:00
0.391
-0.02
(-5.81%)
After-Hours: 20:00
Jupiter Neurosciences Research and Development Expense (Quarterly) : 0.8167M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | 16.94M |
| Phio Pharmaceuticals Corp. | 1.477M |
| Jaguar Health, Inc. | 3.658M |
| MetaVia, Inc. | 1.914M |
| Seastar Medical Holding Corp. | 1.85M |